Poxvirus attack of antiviral defense pathways unleashes an effector-triggered NF-κB response
Science · 12.02.2026 · 391 (6786)
DOI: 10.1126/science.adw4937 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 12.02.2026. Verfasst von Brenna C Remick und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, USA. Hauptthemen laut MEDLINE: Innate Immunity Recognition, Myxoma virus, NF-kappa B, Viral Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Howard Hughes Medical Institute, National Institutes of Health.
Abstract (Originalsprache)
Effector-triggered immunity (ETI) is a form of pathogen sensing that involves detection of pathogen-encoded virulence factors or “effectors.” To discover ETI pathways in mammals, we developed a screening approach in which we expressed individual virulence factors in a human monocyte cell line and assessed transcriptional responses by RNA sequencing. We identified a poxvirus effector, myxoma virus M3.1, which elicited an antiviral nuclear factor κB (NF-κB) response. NF-κB was unleashed by an ETI pathway that sensed M3.1 attack of two antiviral complexes: zinc finger antiviral protein and TBK1. NF-κΒ activation occurred because the proteins inhibited by M3.1—N4BP1, ZC3H12A, and TBK1—are negative regulators of NF-κB. Our study established a systematic approach for the discovery of ETI pathways, and the results illustrated how negative regulators of immune responses may function in pathogen sensing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, USA.
- Howard Hughes Medical Institute, University of California, Berkeley, Berkeley, CA, USA.
- School of Life Sciences and Biodesign Institute, Arizona State University, Tempe, AZ, USA.
- Department of Electrical Engineering and Computer Sciences, University of California, Berkeley, Berkeley, CA, USA.
- Center for Computational Biology, University of California, Berkeley, Berkeley, CA, USA.
- Research Institute of Molecular Pathology, Vienna BioCenter, Vienna, Austria.
ORCID-Profile: Brenna C Remick, Joshua Q Mao, Andrew G Manford, Ami D Gutierrez-Jensen, Allon Wagner, Michael Rape, Grant McFadden, Masmudur M Rahman, Moritz M Gaidt, Russell E Vance
Förderung
- NIAID NIH HHS
- Howard Hughes Medical Institute
- National Institutes of Health
- Boehringer Ingelheim
- Howard Hughes Medical Institute Investigator award
- Howard Hughes Medical Institute Emerging Pathogen Initiative funding
- National Science Foundation Graduate Research Fellowship Program
- H2020 European Research Council
Zitieren
APA
Remick, B. C., Mao, J. Q., Manford, A. G., Gutierrez-Jensen, A. D., Wagner, A., Rape, M., McFadden, G., Rahman, M. M., Gaidt, M. M., & Vance, R. E. (2026). Poxvirus attack of antiviral defense pathways unleashes an effector-triggered NF-κB response. Science, 391(6786). https://doi.org/10.1126/science.adw4937
Vancouver
Remick BC, Mao JQ, Manford AG, Gutierrez-Jensen AD, Wagner A, Rape M, et al. Poxvirus attack of antiviral defense pathways unleashes an effector-triggered NF-κB response. Science. 2026;391(6786). doi:10.1126/science.adw4937
BibTeX
@article{Remick2026,
author = {Remick, Brenna C and Mao, Joshua Q and Manford, Andrew G and Gutierrez-Jensen, Ami D and Wagner, Allon and Rape, Michael and McFadden, Grant and Rahman, Masmudur M and Gaidt, Moritz M and Vance, Russell E},
title = {Poxvirus attack of antiviral defense pathways unleashes an effector-triggered NF-κB response},
journal = {Science},
year = {2026},
volume = {391},
number = {6786},
doi = {10.1126/science.adw4937}
}
EUVIMED